Trial intelligence / Profile preview

Antenatal albendazole treatment for pregnancy outcomes in UITH Ilorin

PACTR202008475715326Completed

Sponsor
Dr Afusat Olabinjo
Start
May 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of albendazole in Helminthiases (2 arms), sponsored by Dr Afusat Olabinjo. Primary endpoint: Maternal stool parasite density. Started May 2020; status: completed.

02

Drugs

albendazole
03

Conditions

Helminthiases

Beyond the preview

Go deeper on PACTR202008475715326.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202008475715326.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call